# Optimal Dose of Proton Pump Inhibitors Following an Upper Gastrointestinal Bleed

> **NCT02235311** · NA · TERMINATED · sponsor: **University of Missouri-Columbia** · enrollment: 3 (actual)

## Conditions studied

- Upper Gastrointestinal Bleed

## Interventions

- **DRUG:** Pantoprazole

## Key facts

- **NCT ID:** NCT02235311
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10
- **Primary completion:** 2015-08-17
- **Final completion:** 2015-08-17
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Difficulty recruiting and consenting participants
- **Last updated:** 2017-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02235311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02235311, "Optimal Dose of Proton Pump Inhibitors Following an Upper Gastrointestinal Bleed". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02235311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*